387 related articles for article (PubMed ID: 30108886)
21. Combretastatin A-4 derived imidazoles show cytotoxic, antivascular, and antimetastatic effects based on cytoskeletal reorganisation.
Mahal K; Biersack B; Caysa H; Schobert R; Mueller T
Invest New Drugs; 2015 Jun; 33(3):541-54. PubMed ID: 25678082
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress imposed in vivo anticancer therapeutic efficacy of novel imidazole-based oxidovanadium (IV) complex in solid tumor.
Ghosh N; Chatterjee S; Biswal D; Pramanik NR; Chakrabarti S; Sil PC
Life Sci; 2022 Jul; 301():120606. PubMed ID: 35508254
[TBL] [Abstract][Full Text] [Related]
23. Imidazole Scaffold Based Compounds in the Development of Therapeutic Drugs.
Hu F; Zhang L; Nandakumar KS; Cheng K
Curr Top Med Chem; 2021; 21(28):2514-2528. PubMed ID: 34047259
[TBL] [Abstract][Full Text] [Related]
24. Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents.
Chen J; Wang Z; Li CM; Lu Y; Vaddady PK; Meibohm B; Dalton JT; Miller DD; Li W
J Med Chem; 2010 Oct; 53(20):7414-27. PubMed ID: 20919720
[TBL] [Abstract][Full Text] [Related]
25. Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents.
Pawar S; Kumar K; Gupta MK; Rawal RK
Anticancer Agents Med Chem; 2021; 21(11):1379-1402. PubMed ID: 32723259
[TBL] [Abstract][Full Text] [Related]
26. Anticancer Potential of Sulfonamide Moieties via In-Vitro and In-Silico Approaches: Comparative Investigations for Future Drug Development.
Wani TA; Zargar S; Alkahtani HM; Altwaijry N; Al-Rasheed LS
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175658
[TBL] [Abstract][Full Text] [Related]
27. Contemporary Progress in the Synthetic Strategies of Imidazole and its Biological Activities.
Soni J; Sethiya A; Sahiba N; Agarwal DK; Agarwal S
Curr Org Synth; 2019; 16(8):1078-1104. PubMed ID: 31984918
[TBL] [Abstract][Full Text] [Related]
28. Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects.
Ansari MF; Khan HY; Tabassum S; Arjmand F
Pharmacol Ther; 2023 Jan; 241():108335. PubMed ID: 36567056
[TBL] [Abstract][Full Text] [Related]
29. p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents.
Nayak SK; Khatik GL; Narang R; Monga V; Chopra HK
Curr Cancer Drug Targets; 2018; 18(8):749-772. PubMed ID: 28669344
[TBL] [Abstract][Full Text] [Related]
30. Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure-activity relationship study.
Meenakshisundaram S; Manickam M; Pillaiyar T
Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900011. PubMed ID: 31596021
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, Biological Profile, and Molecular Docking of Some New Bis- Imidazole Fused Templates and Investigation of their Cytotoxic Potential as Anti-tubercular and/or Anticancer Prototypes.
Kassab RM; Gomha SM; Muhammad ZA; El-Khouly AS
Med Chem; 2021; 17(8):875-886. PubMed ID: 33292124
[TBL] [Abstract][Full Text] [Related]
32. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
33. β-Sitosterol as a Promising Anticancer Agent for Chemoprevention and Chemotherapy: Mechanisms of Action and Future Prospects.
Wang H; Wang Z; Zhang Z; Liu J; Hong L
Adv Nutr; 2023 Sep; 14(5):1085-1110. PubMed ID: 37247842
[TBL] [Abstract][Full Text] [Related]
34. Theoretical Investigation by DFT and Molecular Docking of Synthesized Oxidovanadium(IV)-Based Imidazole Drug Complexes as Promising Anticancer Agents.
Basaleh AS; Alomari FY; Sharfalddin AA; Al-Radadi NS; Domyati D; Hussien MA
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566147
[TBL] [Abstract][Full Text] [Related]
35. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
Warrington RC
Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
[TBL] [Abstract][Full Text] [Related]
36. Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole-Containing Ruthenium Complexes.
Liu P; Jia J; Zhao Y; Wang KZ
Mini Rev Med Chem; 2016; 16(4):272-89. PubMed ID: 26586123
[TBL] [Abstract][Full Text] [Related]
37. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
[TBL] [Abstract][Full Text] [Related]
38. Delivery of anticancer drugs.
Zee-Cheng RK; Cheng CC
Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R
Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802
[TBL] [Abstract][Full Text] [Related]
40. Imidazole inhibits autophagy flux by blocking autophagic degradation and triggers apoptosis via increasing FoxO3a-Bim expression.
Liu Z; Wang Y; Zhao S; Zhang J; Wu Y; Zeng S
Int J Oncol; 2015 Feb; 46(2):721-31. PubMed ID: 25422052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
